Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: Susceptibility data and documentation of presumed infection

Journal of Clinical Microbiology

Volumn 46, Issue 2, 2008, Pages 443-446

  Bishop, Justin A ^a   Chase, Nancy ^a,d   Magill, Shelley S ^a,e   Kurtzman, Cletus P ^b   Fiandaca, Mark J ^c   Merz, William G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

^c AdvanDx Inc   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; PEPTIDE NUCLEIC ACID; POSACONAZOLE; TREHALOSE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; CANDIDA BRACARENSIS; CANDIDA GLABRATA; CANDIDA NIVARIENSIS; CANDIDIASIS; COLOR; DEVICE; DIVERTICULITIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; INTESTINE PERFORATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PELVIS ABSCESS; PHENOTYPE; PRIORITY JOURNAL; SPECIES DIFFERENCE; SPECIES DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; CANDIDA; CANDIDIASIS; CARRIER STATE; DNA, FUNGAL; DNA, RIBOSOMAL; FEMALE; GENES, RRNA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; PELVIC INFECTION; PEPTIDE NUCLEIC ACIDS; PHYLOGENY; RNA, FUNGAL; RNA, RIBOSOMAL; SEQUENCE ANALYSIS, DNA;

CANDIDA; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA;

EID: 38949094247     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01986-07     Document Type: Article

References (14)

1. Alcoba-Florez, J., S. Mendez-Alvarez, J. Cano, J. Guarro, E. Perez-Roth, and M. del Pilar Arevalo. 2005. Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J. Clin. Microbiol. 43:4107-4111.
2. Büchner, T., W. Fegeler, H. Bernhardt, N. Brockmeyer, K.-H. Duswald, M. Herrmann, D. Heuser, U. Jehn, G. Just-Nübling, M. Karthaus, G. Maschmeyer, F.-M. Müller, J. Müller, J. Ritter, N. Roos, M. Ruhnke, A. Schmalreck, R. Schwarze, G. Schwesinger, and G. Silling. 2002. Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur. J. Clin. Microbiol. Infect. Dis. 21:337-352.
3. Correia, A., P. Sampaio, S. James, and C. Pais. 2006. Candida bracarensis, sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int. J. Syst. Evol. Microbiol. 56:313-317.
4. Fujita, S.-I., Y. Senda, T. Okusi, Y. Ota, H. Takada, K. Yamada, and M. Kawano. 2007. Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J. Clin. Microbiol. 45:3459-3461.
5. Kurtzman, C. P., and C. J. Robnett. 1998. Identification and phylogeny of ascomycetous yeasts from analysis of nuclear lare subunit (26S) ribosomal DNA partial sequences. Antonie van Leeuwenhoek 73:331-371.
6. Kurtzman, C. P., and C. J. Robnett. 2003. Phylogenetic relationships among yeasts of the 'Saccharomyces complex' determined by multigene sequence analyses. FEMS Yeast Res. 3:413-432.
7. Li, J., Y. C. Xu, and F. Y. Bai. 2006. Candida pseudorugosa sp. nov., a novel yeast species from sputum. J. Clin. Microbiol. 44:4486-4490.
8. Oliveira, K., G. W. Procop, D. Wilson, J. Coull, and H. Stender. 2002. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J. Clin. Microbiol. 40:247-251.
9. Page, B. T., C. E. Shields, W. G. Merz, and C. P. Kurtzman. 2006. Rapid identification of ascomycetous yeasts from clinical specimens by a molecular method based on flow cytometry and comparison with identifications by phenotypic assays. J. Clin. Microbiol. 44:3167-3171.
10. Pappas, P. G., J. H. Rex, J. D. Sobel, S. G. Filler, W. E. Dismukes, T. J. Walsh, and J. E. Edwards. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 38:161-189.
11. Pfaller, M. A., D. J. Diekema, M. G. Rinaldi, R. Barnes, B. Hu, A. V. Veselov, N. Tiraboschi, E. Nagy, and D. L. Gibbs. 2005. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J. Clin. Microbiol. 43:5848-5859.
12. Sullivan, D. J., T. J. Westerneng, K. A. Haynes, D. E. Bennett, and D. C. Coleman. 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141:1507-1521.
13. Swoboda, S. M., W. G. Merz, and P. A. Lipsett. 2003. Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit. Surg. Infect. 4:345-354.
14. Tavanti, A., A. D. Davidson, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.